πΊπΈ
Karmanos participated in the pivotal international RASolute 302 clinical trial supporting FDA approval DETROIT, Aug. 31, 2026 /PRNewswire/ — The Barbara Ann Karmanos Cancer Institute is now offering a new treatment for pancreatic cancer that will soon change how advanced disease is…
Source: prnewswire
Country: United States